Home Cart Sign in  
Chemical Structure| 1312473-63-4 Chemical Structure| 1312473-63-4

Structure of PF-5081090
CAS No.: 1312473-63-4

Chemical Structure| 1312473-63-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

PF 5081090 is a potent antibacterial agent which disrupts lipid bilayer synthesis through inhibition of LpxC with IC50 of 1.1 nM in Pseudomonas aeruginosa.

Synonyms: LpxC-4

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of PF-5081090

CAS No. :1312473-63-4
Formula : C18H21FN2O6S
M.W : 412.43
SMILES Code : O=C(NO)[C@@](S(=O)(C)=O)(C)CCN1C=CC(C2=CC=C(OC)C=C2F)=CC1=O
Synonyms :
LpxC-4
MDL No. :MFCD22683813

Safety of PF-5081090

Isoform Comparison

Biological Activity

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice (CD-1) Neutropenic mouse thigh infection model Subcutaneous injection 10, 50, 250 mg/kg Single dose Evaluation of Compound 6 efficacy against P. aeruginosa infection in vivo. The highest dose (250 mg/kg) reduced bacterial burden below detection limit for most of the 2-12 hour timeframe. PMC4536915

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.42mL

0.48mL

0.24mL

12.12mL

2.42mL

1.21mL

24.25mL

4.85mL

2.42mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
 

Historical Records

Categories